$ZURA
Zura Bio Limited Class A Ordinary Shares
XNAS
Why is ZURA up today? It is at $6.47 (+10.60%), and our scanner flagged it 77 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ZURA spikes, and full due diligence on ZURA — key stats, earnings, dilution and insider activity. Free.
Get free $ZURA alerts the moment volume spikes
Our scanner flagged $ZURA 77 times in the last 30 days. Create a free account to track $ZURA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $6.47
- Change today
- +10.60%
- Previous close
- $5.85
- 52-week range
- $1.88 – $7.44
- Market cap
- $561M
- Institutional own.
- 76.26%
- Total held
- 89.4%
- Tradeable float
- 10.1M 11% of shares · after 13% insiders + 76% institutions
- Avg daily volume
- 1.0M
- Exchange
- XNAS
- 5mthin
- 2.0x
- 15mthin
- 2.0x
- 1hthin
- 2.5x
- 1D
- 2.9x
Get free ZURA + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ZURA up today?
ZURA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on ZURA today, peaking at 9.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystsimilar expressions are intended to identify such forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on currentReported IL-17 and BAFF among the most clinically validated pathways in immunologic disorders1,2Reported Orthogonal nature of IL-17 and BAFF offers potential to modulate non-redundant pathwaysReported Potent engagement of targets and low immunogenicity observed in Phase 1, from an SEC filing. Read it →Latest filing144Notice of proposed insider sale (144)Aug 18, 2026 · 6 days agoAnalyst data via Nasdaq. Not investment advice.
Insiders
1 open-market buy0 buys, 0 sells last 3 months (1/0 over 12 months)Show 5 recent transactionsMinimize 5 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Ai Biotechnology Llc Beneficial Owner (10%) | Bought (open market) | +2.00M 2.1% of company | added 44% | 6.55M | $12.5M at $6.25 | Feb 26, 26 |
Thiara Parvinder Director | Sold (automatic/other) | -1.00M 1.0% of company | n/a | n/a | $2.7M at $2.73 | Nov 25, 24 |
Davis Kim Officer | Acquired (grant/award) | +1K | added 100% | 2K | n/a | Sep 16, 24 |
Thiara Parvinder Director | Sold (automatic/other) | -3.80M 4.0% of company | sold 79% | 1.00M | $10.3M at $2.70 | Sep 11, 24 |
Sidhu Someit Director | Sold (automatic/other) | -52K 0.05% of company | sold 2.4% | 2.09M | $200K at $3.87 | Sep 4, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $ZURA runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 18,200,000 new shares · At-the-market (ATM) program — sells new shares into the market gradually over time · About $114.0M in size · Priced at $6.25/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$ZURA Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ZURA Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
ZURA stock FAQ
Why is $ZURA up today?
ZURA is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 18 unusual-volume and momentum alerts on ZURA today, peaking at 9.6x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
What is the ZURA stock price today?
ZURA last traded at $6.47, up 10.60% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ZURA alerts?
The ZURA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ZURA 77 times in the last 30 days.
What exchange is ZURA on?
ZURA (Zura Bio Limited Class A Ordinary Shares) trades on XNAS, with a market cap of about $561M.
Is ZURA good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ZURA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.